Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01969812 · ClinicalTrials.gov registry record · NA
Tolerability and Satisfaction With Evie
A NA study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 22
- Enrollment target
NCT01969812 is a NA study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 22 participants.
The verdict
NCT01969812, a NA study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
Study Summary
The purpose of this study is to determine patient satisfaction and tolerability of the Evie® slow-release insemination device for US population. Additionally, to assess cramping with the device and to determine pregnancy rates using the slow insemination device compared to standard IUI.
Interventions
- DEVICE Evie Slow-release Insemination Device
- OTHER Traditional Intrauterine Insemination
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2014-01 |
| Est. Completion | 2015-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01969812
The ClinicalTrials.gov registry entry for NCT01969812 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Evie Slow-release Insemination Device is the first listed.
NCT01969812 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01969812 about?
NCT01969812 is a clinical study titled "Tolerability and Satisfaction With Evie". The purpose of this study is to determine patient satisfaction and tolerability of the Evie® slow-release insemination device for US population. Additionally, to assess cramping with the device and to determine pregnancy rates using the slow insemination device compared to standard IUI.
What is the current status of trial NCT01969812?
This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2014-01. Estimated completion is 2015-03.
What interventions are being tested in trial NCT01969812?
The interventions under investigation include: Evie Slow-release Insemination Device (DEVICE), Traditional Intrauterine Insemination (OTHER).
Who is sponsoring clinical trial NCT01969812?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.